Slowing the Rush to Genetically Modified Babies
By Enola Aird,
MomsRising
| 03. 22. 2014
We are heading toward a slippery slope. The United Kingdom is moving closer to allowing scientists to create genetically modified children – something no country in the world currently authorizes.
I posted
in December about how the United States and the U.K. were going down a dangerous road. The Human Fertilisation and Embryology Authority (HFEA), the key U.K. regulator on these matters,
recently issued (on very short notice), a “Call for evidence” on issues of safety and efficacy, with a deadline of today, March 21, 2014.
HFEA has released draft regulations that would allow clinical trials of techniques that would create “three-person embryos.” These methods are proposed as a way to help a very small number of women with certain mitochondrial diseases to avoid passing those diseases on to genetically related children. The draft notes that “the Government has decided to proceed with regulations. However, before taking the decision to submit regulations for the scrutiny and approval of Parliament, we will…reconvene the Expert Panel a further time to provide an updated assessment of the safety and efficacy of these techniques.”...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...